Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary Anesthesia Breathing Machine Market Strategic Research Report

Global Veterinary Anesthesia Breathing Machine Market Strate…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Anesthesia Breathing Machine Market
$2592025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Mobile Type, Wall-mount Type, Desktop Type

By Application: Clinical Surgery, Laboratory Experiment, Teaching and Training, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: RWD Life Science, Mindray Animal Medical Technology, Vetland Medical, Midmark, Lory Progetti Veterinari, Rothacher Medical, SOMNI Scientifics, Kent Scientific, Dispomed, Acoma Medical, A.M. Bickford, VetEquip, Shenzhen Comen Medical Instruments, Shenzhen Prunus Medical, Shanghai Raymain Information Technology, Shenzhen Bizvet Bio-tech, Dolphinmed, Shanghai TOW Intelligent Technology

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 135 pages
Market size 2025
$259
Million USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$376.8
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Veterinary Anesthesia Breathing Machine market size is predicted to grow from US$ 259 million in 2025 to US$ 376 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

A veterinary anesthesia breathing machine is a precision medical device designed to deliver controlled concentrations of anesthetic gases and oxygen to animals during surgical, diagnostic, and therapeutic procedures, ensuring safe and effective anesthesia management and respiratory support. The system integrates gas flow control, vaporization, breathing circuits, and monitoring modules to regulate and recycle anesthetic gases. Its upstream supply chain primarily includes suppliers of high-purity medical gas cylinders, flowmeters, vaporizers, precision valves, pressure gauges, breathing circuits, stainless steel or aluminum alloy casings, medical-grade plastic components, and electronic parts. The downstream market mainly consists of veterinary hospitals, animal clinics, research institutions, laboratory animal centers, and specialized animal surgical facilities. The global production capacity of veterinary anesthesia breathing machines is approximately 47,900 units, with actual sales of about 41,200 units, representing a capacity utilization rate of around 86%. The average market price is approximately USD 5,247 per unit, and the average gross profit margin ranges between 35% and 45%.

The global veterinary anesthesia breathing machine market has shown steady growth in recent years, driven primarily by expanding demand in both the pet healthcare and scientific research sectors. On one hand, the global pet population continues to rise, and the rapid development of the pet economy has significantly boosted the need for veterinary medical services. Veterinary anesthesia breathing machines, known for their advantages such as rapid induction, quick recovery, precise control of anesthesia depth, and low animal mortality rates, have become standard equipment in animal hospitals, research institutions, and veterinary schools. In particular, China’s rapidly expanding pet healthcare market has spurred strong demand for veterinary medical devices. As pet healthcare is largely a self-funded service with low policy risk, combined with growing public awareness of animal welfare, gas-based anesthesia breathing systems are increasingly becoming standard configurations in veterinary clinics. Although China’s veterinary medical device industry remains in its early stages with low market concentration and limited technical and market presence of domestic brands, continuous technological progress and product quality improvements among local manufacturers are expected to create substantial opportunities for import substitution and future market growth.

In the field of scientific research and laboratory applications, animal anesthesia technologies are widely used in biopharmaceutical development, preclinical testing, and teaching laboratories. Compared with traditional injectable anesthesia methods, gas-based anesthesia breathing systems offer significant advantages in safety, controllability, and animal welfare. In developed regions such as Europe and North America, inhalation anesthesia is almost universally adopted for laboratory animals, ranging from rodents to canines and primates. In contrast, many research institutions in China still rely on injectable anesthesia due to its lower cost, though it is less precise in dosage control, prolongs recovery time, and increases mortality risk. As animal management regulations and ethical standards continue to improve, the adoption rate of anesthesia breathing machines in scientific research is gradually increasing, with wider application expected in the coming years.

Looking ahead, the global veterinary anesthesia breathing machine market is expected to experience simultaneous structural optimization and demand expansion. The continuous growth of the pet healthcare sector, standardization of experimental animal research, and the strengthening of animal welfare regulations worldwide will collectively drive deeper market penetration of anesthesia breathing systems. However, the industry still faces certain constraints, including high equipment prices, rising maintenance costs, insufficient infrastructure in some regions, and a shortage of trained veterinary professionals. Overall, with declining manufacturing costs, accelerated technological innovation, and expanding clinical demand, the long-term outlook for the global veterinary anesthesia breathing machine market remains optimistic, with the industry expected to evolve toward higher performance, greater safety, and increased automation.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Anesthesia Breathing Machine market?

What factors are driving Veterinary Anesthesia Breathing Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Anesthesia Breathing Machine market opportunities vary by end market size?

How does Veterinary Anesthesia Breathing Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Veterinary Anesthesia Breathing Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Mobile Type
  • Wall-mount Type
  • Desktop Type

Segment by Animal Type

  • Small Companion Animals
  • Large Livestock Animals
  • Laboratory Animals

Segment by Application

  • Pet Hospitals and Clinics
  • Research Institutions
  • University of Animal Husbandry and Veterinary Medicine
  • Others

Segment by Application

  • Clinical Surgery
  • Laboratory Experiment
  • Teaching and Training
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary Anesthesia Breathing Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Clinical Surgery, Laboratory Experiment, Teaching and Training evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary Anesthesia Breathing Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$259
2025
Forecast
$376.8
2032
CAGR
5.5%
2025–2032
Régions
5
global
Key companies
RWD Life ScienceMindray Animal Medical TechnologyVetland MedicalMidmarkLory Progetti VeterinariRothacher MedicalSOMNI ScientificsKent Scientific
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Mobile TypeWall-mount TypeDesktop Type
By Application
Clinical SurgeryLaboratory ExperimentTeaching and TrainingOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Mobile Type
  • 3.1.3 Wall-mount Type
  • 3.1.4 Desktop Type
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Clinical Surgery
  • 4.1.3 Laboratory Experiment
  • 4.1.4 Teaching and Training
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 RWD Life Science
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Mindray Animal Medical Technology
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Vetland Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Midmark
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Lory Progetti Veterinari
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Rothacher Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 SOMNI Scientifics
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Kent Scientific
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Dispomed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Acoma Medical
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 A.M. Bickford
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 VetEquip
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Shenzhen Comen Medical Instruments
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Shenzhen Prunus Medical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shanghai Raymain Information Technology
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shenzhen Bizvet Bio-tech
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Dolphinmed
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Shanghai TOW Intelligent Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Veterinary Anesthesia Breathing Machine market?
The global Veterinary Anesthesia Breathing Machine market is estimated at US$ 259 million in 2025 (base year) and is projected to reach US$ 376 million by 2032.
What is the forecast CAGR for the Veterinary Anesthesia Breathing Machine market?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 259 million in 2025 to US$ 376 million in 2032, roughly 1.5 times its base-year value.
What is Veterinary Anesthesia Breathing Machine?
A veterinary anesthesia breathing machine is a precision medical device designed to deliver controlled concentrations of anesthetic gases and oxygen to animals during surgical, diagnostic, and therapeutic procedures, ensuring safe and effective anesthesia management and respiratory support. The system integrates gas flow control, vaporization, breathing circuits, and monitoring modules to regulate and recycle anesthetic gases.
What are the main segments of the Veterinary Anesthesia Breathing Machine market by type?
By type, the market is segmented into Mobile Type, Wall-mount Type and Desktop Type.
Which applications drive demand in the Veterinary Anesthesia Breathing Machine market?
Key applications covered include Clinical Surgery, Laboratory Experiment, Teaching and Training and Other.
Who are the key players in the Veterinary Anesthesia Breathing Machine market?
Key players profiled include RWD Life Science, Mindray Animal Medical Technology, Vetland Medical, Midmark, Lory Progetti Veterinari, Rothacher Medical, SOMNI Scientifics and Kent Scientific, among 18 companies covered in total.
Which regions and countries are covered for Veterinary Anesthesia Breathing Machine?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Veterinary Anesthesia Breathing Machine market?
The global veterinary anesthesia breathing machine market has shown steady growth in recent years, driven primarily by expanding demand in both the pet healthcare and scientific research sectors.
What challenges does the Veterinary Anesthesia Breathing Machine market face?
However, the industry still faces certain constraints, including high equipment prices, rising maintenance costs, insufficient infrastructure in some regions, and a shortage of trained veterinary professionals.
Who should buy the Veterinary Anesthesia Breathing Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Clinical Surgery, Laboratory Experiment and Teaching and Training, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary Anesthesia Breathing Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.